Goldman Sachs upgraded Roche (RHHBY) to Neutral from Sell.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RHHBY:
- White House releases details on Trump ‘Great Healthcare Plan’
- Street sees buying opportunity as Disc Medicine slips on FDA review delay
- Stifel sees weakness in Disc Medicine shares as buying opportunity
- Trump Trade: Trump administration moves to end pharma trade probe
- AbbVie (ABBV) Commits $100B in U.S. Investment, Inks Deal with Trump to Avoid Tariffs